Atea Pharmaceuticals, Inc. - COM (AVIR)

Historical Portfolio Holders from Q4 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
53.9 M
Holdings value Q1 2024
$218 M
Value change Q1 2024
-$1.67 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
108
Number of buys Q1 2024
50
Number of sells Q1 2024
-51
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
04683R106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 53.9 M $218 M -$1.67 M $4.04 108
2023 Q4 54.5 M $166 M -$2.06 M $3.05 101
2023 Q3 56.8 M $170 M -$1.91 M $3.00 114
2023 Q2 56.9 M $213 M +$726 K $3.74 128
2023 Q1 56.8 M $190 M -$5.74 M $3.35 126
2022 Q4 57.8 M $278 M -$5.11 M $4.81 126
2022 Q3 56.9 M $323 M -$1.87 M $5.69 109
2022 Q2 57.2 M $405 M +$19.3 M $7.10 117
2022 Q1 52.4 M $378 M -$6.73 M $7.22 116
2021 Q4 52.7 M $471 M -$416 M $8.94 132
2021 Q3 56.8 M $1.99 B -$21.9 M $35.06 141
2021 Q2 58.9 M $1.27 B +$154 M $21.48 100
2021 Q1 49.4 M $3.04 B +$30.5 M $61.75 80
2020 Q4 49.9 M $2.07 B +$1.82 B $41.78 69